🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,290.00
-60.00 (-2.55%)
Nov 18, 2026, 3:30 PM KST

HLB Life Science Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22,846-99,7946,138-5,983-54,277-49,152
Depreciation & Amortization
8,8155,2475,9017,6965,2232,484
Loss (Gain) From Sale of Assets
-2,9223,130-23.84234.83-3,157-593.47
Asset Writedown & Restructuring Costs
6,0736,07324,16237,55314,80213,786
Loss (Gain) From Sale of Investments
-13,90263,329-61,670-81,33620,54824,871
Loss (Gain) on Equity Investments
-692.99-2,406-1,3542,607-2,602-3,576
Stock-Based Compensation
52.155.35----
Provision & Write-off of Bad Debts
-119.89-166.33-3,233-91.76-173.85-292.94
Other Operating Activities
5,2807,6332,92323,5433,135-2,213
Change in Accounts Receivable
-3,911-4,541-6,7804,03110,149-1,552
Change in Inventory
-1,707-3,460-421.435,300-2,515221.34
Change in Accounts Payable
-1,985-479.081,508-4,072-5,6104,730
Change in Other Net Operating Assets
2,1032,447845.87501.09-15,265-2,798
Operating Cash Flow
-25,763-22,933-32,005-10,016-29,744-14,084
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-11,422-25,582-27,296-20,618-10,676-2,421
Sale of Property, Plant & Equipment
917.85314.498.786,652832.863,526
Cash Acquisitions
0-3,070--9,029-43,184-
Divestitures
33,95817,355----
Sale (Purchase) of Intangibles
-409.33-360.24-170.68326.9-1,044-46
Investment in Securities
-31,084-24,437-8,91413,786-25,5975,712
Other Investing Activities
921.691,147-1,50006,8461,920
Investing Cash Flow
-7,118-34,633-37,781-8,883-72,6438,822

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-18,94048,0007,7107,4001,000
Long-Term Debt Issued
-18,82977,57010,87098,760-
Total Debt Issued
83,18937,769125,57018,580106,1601,000
Short-Term Debt Repaid
--5,147-49,307-5,000-4,000-1,000
Long-Term Debt Repaid
--14,356-77,296-8,256-1,322-642.24
Total Debt Repaid
-65,319-19,503-126,603-13,256-5,322-1,642
Net Debt Issued (Repaid)
17,87018,266-1,0335,324100,837-642.24
Issuance of Common Stock
-108.61106,977-1,000129.25
Repurchase of Common Stock
----679.97--
Other Financing Activities
133-115.31-200.49142.28259.37-128.1
Financing Cash Flow
18,00318,259105,7444,786102,096-641.09

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-46.68-127.1-0.52-97.0415.560.05
Miscellaneous Cash Flow Adjustments
-0---0--
Net Cash Flow
-14,925-39,43435,956-14,210-275.23-5,903

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-37,185-48,515-59,301-30,634-40,420-16,505
Free Cash Flow Growth
------
Free Cash Flow Margin
-66.42%-106.04%-180.96%-31.26%-40.59%-30.85%
Free Cash Flow Per Share
-304.96-398.19-526.20-300.99-400.32-166.14
Levered Free Cash Flow
-14,841-42,441-60,323-29,493-33,595-10,410
Unlevered Free Cash Flow
-7,421-35,101-49,824-15,961-27,426-9,625

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
7,6453,5962,9192,728674.73250.99
Cash Income Tax Paid
230.59-52.917,785-703.651,140-569.35
Change in Working Capital
-5,501-6,033-4,8485,761-13,241601.65